228 related articles for article (PubMed ID: 9682349)
1. A benefit-cost analysis of two-dose measles immunization in Canada.
Pelletier L; Chung P; Duclos P; Manga P; Scott J
Vaccine; 1998; 16(9-10):989-96. PubMed ID: 9682349
[TBL] [Abstract][Full Text] [Related]
2. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
[TBL] [Abstract][Full Text] [Related]
3. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
Heath TC; Burgess MA; O'Brien ED
Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
[No Abstract] [Full Text] [Related]
4. [Economic evaluation on different two-dose-vaccination-strategies related to Measles, Mumps and Rubella Combined Attenuated Live Vaccine].
He HQ; Zhang B; Yan R; Li Q; Fu J; Tang XW; Zhou Y; Deng X; Xie SY
Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1121-6. PubMed ID: 27539345
[TBL] [Abstract][Full Text] [Related]
5. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
[TBL] [Abstract][Full Text] [Related]
6. Catch-up immunization programs will eliminate measles threat for most schoolchildren.
Rafuse J
CMAJ; 1996 May; 154(10):1567-8. PubMed ID: 8625011
[TBL] [Abstract][Full Text] [Related]
7. Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Watson JC; Hadler SC; Dykewicz CA; Reef S; Phillips L
MMWR Recomm Rep; 1998 May; 47(RR-8):1-57. PubMed ID: 9639369
[TBL] [Abstract][Full Text] [Related]
8. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP).
McLean HQ; Fiebelkorn AP; Temte JL; Wallace GS;
MMWR Recomm Rep; 2013 Jun; 62(RR-04):1-34. PubMed ID: 23760231
[TBL] [Abstract][Full Text] [Related]
9. Benefits, risks and costs of immunization for measles, mumps and rubella.
White CC; Koplan JP; Orenstein WA
Am J Public Health; 1985 Jul; 75(7):739-44. PubMed ID: 3923849
[TBL] [Abstract][Full Text] [Related]
10. A second dose of MMR vaccine for children in the United Kingdom.
Commun Dis Rep CDR Wkly; 1996 Jul; 6(30):259. PubMed ID: 8755703
[No Abstract] [Full Text] [Related]
11. [Vaccination rate for triple measles-rubella-mumps vaccine in Empoli Val d'Elsa area health district U.S.L. 11, Tuscany Region].
Salvadori P
Ann Ig; 1998; 10(1):19-24. PubMed ID: 9616974
[No Abstract] [Full Text] [Related]
12. From the Centers for Disease Control and Prevention. Measles--United States, 1996, and the interruption of indigenous transmission.
JAMA; 1997 May; 277(17):1345-6. PubMed ID: 9134928
[No Abstract] [Full Text] [Related]
13. Moving the second dose of measles-mumps-rubella vaccine to school entry: implications for control of rubella.
Heath TC; Burgess MA; Forrest JM
Commun Dis Intell; 1998 Aug; 22(8):157-8. PubMed ID: 9735550
[No Abstract] [Full Text] [Related]
14. [Certain problems with limits of immunity against measles, mumps and rubella].
Magdzik W
Przegl Epidemiol; 1993; 47(1-2):47-53. PubMed ID: 8351387
[TBL] [Abstract][Full Text] [Related]
15. Sentinel surveillance shows small decline in MMR coverage.
Commun Dis Rep CDR Wkly; 1998 Sep; 8(36):317, 320. PubMed ID: 9782644
[No Abstract] [Full Text] [Related]
16. Mumps and rubella consensus conference.
Can Commun Dis Rep; 1994 Oct; 20(19):165-76. PubMed ID: 7804152
[No Abstract] [Full Text] [Related]
17. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
[TBL] [Abstract][Full Text] [Related]
18. Measles, mumps, and rubella: recommendations for children/adolescents.
Nurse Pract; 1996 Oct; 21(10):88, 91-2, 94. PubMed ID: 8895194
[No Abstract] [Full Text] [Related]
19. Measles-mumps-rubella immunization of susceptible hospital employees during a community measles outbreak: cost-effectiveness and protective efficacy.
Stover BH; Adams G; Kuebler CA; Cost KM; Rabalais GP
Infect Control Hosp Epidemiol; 1994 Jan; 15(1):18-21. PubMed ID: 8133004
[TBL] [Abstract][Full Text] [Related]
20. Measles-rubella mass immunization campaign in Albania, November 2000.
Bino S; Kakarriqi E; Xibinaku M; Ion-Nedelcu N; Bukli M; Emiroglu N; Uzicanin A
J Infect Dis; 2003 May; 187 Suppl 1():S223-9. PubMed ID: 12721917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
